Cooper Cash Flow from Operating Activities 2012-2026 | COO
Cooper annual/quarterly cash flow from operating activities history and growth rate from 2012 to 2026. Cash flow from operating activities can be defined as a company's cash flows from operations.
- Cooper cash flow from operating activities for the quarter ending January 31, 2026 was $0.796B, a 12.24% increase year-over-year.
- Cooper cash flow from operating activities for the twelve months ending January 31, 2026 was $1.822B, a 20.89% increase year-over-year.
- Cooper annual cash flow from operating activities for 2025 was $0.796B, a 12.24% increase from 2024.
- Cooper annual cash flow from operating activities for 2024 was $0.709B, a 16.76% increase from 2023.
- Cooper annual cash flow from operating activities for 2023 was $0.608B, a 12.26% decline from 2022.
|
Cooper Annual Cash Flow Ops (Millions of US $) |
|
|---|---|
| 2025 | $796 |
| 2024 | $709 |
| 2023 | $608 |
| 2022 | $692 |
| 2021 | $739 |
| 2020 | $487 |
| 2019 | $713 |
| 2018 | $669 |
| 2017 | $594 |
| 2016 | $510 |
| 2015 | $391 |
| 2014 | $455 |
| 2013 | $416 |
| 2012 | $315 |
| 2011 | $336 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical & Dental Supplies | $13.894B | $4.092B |
| The Cooper Companies Inc, is a specialty medical device company operating on a global basis. Cooper has two business segments- CooperVision and CooperSurgical. CooperVision manufactures and sells a wide range of contact lenses. CooperVision develops manufactures and markets a broad range of single-use, two-week and monthly contact lenses, featuring advanced materials and optics. The company's products are primarily designed for solving vision challenges like astigmatism, presbyopia and ocular dryness.?CooperSurgical sells a variety of medical devices and surgical instruments that are primarily utilized by gynecologists and obstetricians. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| McKesson (MCK) | United States | $106.025B | 23.03 |
| Cardinal Health (CAH) | United States | $50.715B | 22.43 |
| Becton Dickinson (BDX) | United States | $43.913B | 11.10 |
| West Pharmaceutical Services (WST) | United States | $18.493B | 35.19 |
| Straumann Holding AG (SAUHY) | Switzerland | $16.902B | 0.00 |
| Align Technology (ALGN) | United States | $12.400B | 21.09 |
| Henry Schein (HSIC) | United States | $8.645B | 15.16 |
| Merit Medical Systems (MMSI) | United States | $4.072B | 19.84 |
| DENTSPLY SIRONA (XRAY) | United States | $2.339B | 7.36 |
| STAAR Surgical (STAA) | United States | $1.309B | 0.00 |
| CONMED (CNMD) | United States | $1.107B | 7.97 |
| Pro-Dex (PDEX) | United States | $0.165B | 19.65 |
| Lifevantage (LFVN) | United States | $0.053B | 5.46 |
| Axe Compute (AGPU) | United States | $0.022B | 0.00 |